COX-2, the rate-limiting enzyme in the biosynthesis of prostaglandins (PGs) and thromboxanes, is one example of a cytoprotective response to mucosal injury that, when dysregulated, may promote epithelial transformation to an invasive phenotype and the development of cancer [8,10]. This evidence concerns the gene PTGS2 and cancer.